Saturday, May 19, 2012 12:50:07 AM
For heaven's sake, you're not investing anymore. You're speculating.
And it's unintelligent speculation at best. The stock market is not a game! That's what Vegas is for, and to put it bluntly, you're playing Vegas odds at this point. From a business sense, this is not an investment in any sense of the word. If you wanna invest, the company is overvalued right now based on known information, even at this price. It would be nice if we could all be Warren Buffet and pick great companies at great prices that we can hold indefinitely, but market timing is part of REAL investing for most of us lesser pions, and right now, at this price, the timing is all wrong for an 'investment'.
If that's your style and strategy, so be it, but don't drag other people into it with your 'advice'.
And it's unintelligent speculation at best. The stock market is not a game! That's what Vegas is for, and to put it bluntly, you're playing Vegas odds at this point. From a business sense, this is not an investment in any sense of the word. If you wanna invest, the company is overvalued right now based on known information, even at this price. It would be nice if we could all be Warren Buffet and pick great companies at great prices that we can hold indefinitely, but market timing is part of REAL investing for most of us lesser pions, and right now, at this price, the timing is all wrong for an 'investment'.
If that's your style and strategy, so be it, but don't drag other people into it with your 'advice'.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
